Rare tumours such as penile carcinoma have been largely neglected by the urology
scientific community in favour of more common—and, therefore, more easily fundable …

Background: Human papillomavirus (HPV) vaccination was introduced in 2006 for females
and in 2011 for males. Objective: To estimate vaccine impact and effectiveness against …

Objectives Economic evaluations of vaccines should accurately represent all relevant
economic and health consequences of vaccination, including losses due to adverse events …

Human papillomavirus (HPV) can cause several diseases, including cancers, in both sexes.
In January 2020, the Hong Kong government launched a school-based vaccination program …

Objective To assess the public health impact and cost effectiveness of gender-neutral
vaccination (GNV) versus female-only vaccination (FOV) with human papillomavirus (HPV) …

Vaccination is effective in preventing human papillomavirus (HPV) infection. It still remains
debatable whether males should be included in a vaccination program and unclear how to …

Background The 2021 Chinese Expert Consensus on the Clinical Application of the Human
Papillomavirus (HPV) Vaccine recommended vaccination for women who previously …

Background: Routine human papillomavirus (HPV) immunization in Belgium is currently
regionally managed, with school-aged girls receiving the 9-valent HPV (9vHPV) vaccine in …

Abstract Background The French Cancer Plan 2014–2019 had a target of 60% HPV vaccine
coverage. The PAPILLON study investigated the annual age-specific vaccination initiation …

This study aimed to determine the cost-effectiveness of vaccination against HPV. An age–
sex structured dynamic disease transmission model was created to estimate the spread of …